Barings Corporate Investors MCI 深 滬
等待開盤 11-05 09:30:00 美东时间
20.51
-0.250
-1.20%
華盛通- 最 高20.75
- 今 開20.60
- 成交量 2.24万股
- 最 低 20.50
- 昨 收 20.76
- 總市值 4.19亿
- 52周最高 24.04
- 市盈率 靜 --
- 換手率 0.11%
- 52周最低 17.40
- 委 比 33.33%
- 總股本 2044.46万
- 歷史最高 24.04
- 量 比 0.56
- 振 幅 1.20%
- 歷史最低 0.335
- 每 手 1
- 風險率 1.11%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Quest Diagnostics' New Blood Tests Accurately Detect Alzheimer's, Study Finds
Two blood tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer's disease pathology in symptomatic patients, supporting diagnosis, according to a new study in Neurology®
10-27 19:47
Health Canada Grants Authorization for Leqembi® (lecanemab)
STOCKHOLM, Oct. 26, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Health Canada has issued a Notice of Compliance with Conditions (...
10-27 10:56
Science Applications International Appoints James Reagan As Interim CEO
Science Applications International Corporation (NASDAQ:SAIC), a premier Fortune 500® company driving our nation's digital transformation across the defense, space, civilian, and intelligence markets, today announced
10-24 04:17
Leqembi® Iqlik™ (lecanemab-irmb) selected by TIME as one of the best innovations of 2025
STOCKHOLM, Oct. 14, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi Iqlik, a subcutaneous autoinjector formulation of lecanem...
10-14 13:14
Barings Corporate Investors declares $0.40 dividend
Barings Corporate Investors (NYSE:MCI) declares $0.40/share quarterly dividend, in line with previous. Forward yield 7.96% Payable Nov. 14; for shareholders of record Nov. 3; ex-div Nov. 3. See MCI Di...
10-10 03:43
Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.
STOCKHOLM, Oct. 6, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab-irmb subcutaneous injection (U.S. brand name: Leqembi Iq...
10-07 06:02
Eisai And Biogen Announce Lecanemab-Irmb Subcutaneous Injection Is Now Available In US As Maintenance Dosing Regimen For AD Treatment
New LEQEMBI Companion™ program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who can provide patients with injection training, and an injection
10-07 04:34
Eisai And Biogen's LEQEMBI Approved By Australia's TGA For Early Alzheimer's In ApoEε4 Non-Carriers And Heterozygotes
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (NASDAQ:BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen"))) announced today that the
09-24 19:34
Leqembi® approved for the treatment of early Alzheimer's disease in Australia
STOCKHOLM, Sept. 24, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) announced today that the Therapeutic Goods Administration (TGA) of Australia has approved lecanemab...
09-24 14:56
清华大学张健：建议酒业加强金融体系和绿色人才培养，2030年将新增3700万个绿色就业岗位
专题：2025全国理性饮酒宣传周新闻发布会 9月18日，由中国酒业协会主办，酒与社会责任促进工作委员会承办，华润啤酒（控股）有限公司协办的...
09-19 15:05
公司簡介
公司名稱
|
Barings Corporate Investors
|
行業分類
|
--
|
業務描述
|
Barings Corporate Investors, a closed-end investment company traded on the New York Stock Exchange, invests in small and middle market companies. The fund provides financing in the form of mezzanine debt and equity for acquisition transactions. Its principal investments are privately placed, below-investment grade, long term debt obligations with equity features such as common stock, warrants, conversion rights, or other equity features and, occasionally, preferred stocks.
|
Quest Diagnostics' New Blood Tests Accurately Detect Alzheimer's, Study Finds
Two blood tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer's disease pathology in symptomatic patients, supporting diagnosis, according to a new study in Neurology®
10-27 19:47
Health Canada Grants Authorization for Leqembi® (lecanemab)
STOCKHOLM, Oct. 26, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Health Canada has issued a Notice of Compliance with Conditions (...
10-27 10:56
Science Applications International Appoints James Reagan As Interim CEO
Science Applications International Corporation (NASDAQ:SAIC), a premier Fortune 500® company driving our nation's digital transformation across the defense, space, civilian, and intelligence markets, today announced
10-24 04:17
Leqembi® Iqlik™ (lecanemab-irmb) selected by TIME as one of the best innovations of 2025
STOCKHOLM, Oct. 14, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi Iqlik, a subcutaneous autoinjector formulation of lecanem...
10-14 13:14
Barings Corporate Investors declares $0.40 dividend
Barings Corporate Investors (NYSE:MCI) declares $0.40/share quarterly dividend, in line with previous. Forward yield 7.96% Payable Nov. 14; for shareholders of record Nov. 3; ex-div Nov. 3. See MCI Di...
10-10 03:43
Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.
STOCKHOLM, Oct. 6, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab-irmb subcutaneous injection (U.S. brand name: Leqembi Iq...
10-07 06:02
Eisai And Biogen Announce Lecanemab-Irmb Subcutaneous Injection Is Now Available In US As Maintenance Dosing Regimen For AD Treatment
New LEQEMBI Companion™ program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who can provide patients with injection training, and an injection
10-07 04:34
Eisai And Biogen's LEQEMBI Approved By Australia's TGA For Early Alzheimer's In ApoEε4 Non-Carriers And Heterozygotes
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (NASDAQ:BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen"))) announced today that the
09-24 19:34
Leqembi® approved for the treatment of early Alzheimer's disease in Australia
STOCKHOLM, Sept. 24, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) announced today that the Therapeutic Goods Administration (TGA) of Australia has approved lecanemab...
09-24 14:56
清华大学张健：建议酒业加强金融体系和绿色人才培养，2030年将新增3700万个绿色就业岗位
专题：2025全国理性饮酒宣传周新闻发布会 9月18日，由中国酒业协会主办，酒与社会责任促进工作委员会承办，华润啤酒（控股）有限公司协办的...
09-19 15:05
派息除權日
|
每股總股息
| 派息日期 |
2025-11-03
|
0.40
|
2025-11-14
|
2025-08-29
|
0.40
|
2025-09-12
|
2025-05-30
|
0.40
|
2025-06-13
|
2024-12-30
|
0.50
|
2025-01-17
|
2024-11-04
|
0.40
|
2024-11-15
|
2024-08-26
|
0.40
|
2024-09-13
|
2024-05-31
|
0.39
|
2024-06-14
|
2023-12-28
|
0.38
|
2024-01-19
|
2023-11-03
|
0.37
|
2023-11-17
|
2023-08-25
|
0.35
|
2023-09-08
|
2023-05-30
|
0.32
|
2023-06-09
|
2022-12-29
|
0.28
|
2023-01-20
|
2022-11-04
|
0.18
|
2022-11-18
|
2022-08-26
|
0.24
|
2022-09-09
|
2022-05-27
|
0.24
|
2022-06-10
|
2021-12-29
|
0.24
|
2022-01-14
|
2021-11-05
|
0.24
|
2021-11-19
|
2021-07-30
|
0.24
|
2021-08-13
|
2021-04-30
|
0.24
|
2021-05-14
|
2020-12-30
|
0.24
|
2021-01-15
|
2020-10-30
|
0.24
|
2020-11-13
|
2020-07-31
|
0.24
|
2020-08-14
|
2020-05-01
|
0.24
|
2020-05-15
|
2019-12-30
|
0.30
|
2020-01-17
|
2019-11-01
|
0.30
|
2019-11-15
|
2019-08-02
|
0.30
|
2019-08-16
|
2019-05-03
|
0.30
|
2019-05-17
|
2018-12-28
|
0.30
|
2019-01-11
|
2018-10-26
|
0.30
|
2018-11-09
|
2018-08-03
|
0.30
|
2018-08-17
|
2018-05-04
|
0.30
|
2018-05-18
|
2017-12-28
|
0.30
|
2018-01-12
|
2017-10-27
|
0.30
|
2017-11-10
|
2017-07-28
|
0.30
|
2017-08-11
|
2017-05-02
|
0.30
|
2017-05-12
|
2016-12-28
|
0.30
|
2017-01-13
|
2016-11-03
|
0.30
|
2016-11-18
|
2016-07-28
|
0.30
|
2016-08-12
|
2016-04-28
|
0.30
|
2016-05-13
|
2015-12-29
|
0.30
|
2016-01-15
|
2015-11-02
|
0.30
|
2015-11-13
|
2015-07-30
|
0.30
|
2015-08-14
|
2015-04-29
|
0.30
|
2015-05-15
|
2014-12-29
|
0.30
|
2015-01-16
|
2014-10-30
|
0.30
|
2014-11-14
|
2014-07-30
|
0.30
|
2014-08-15
|
2014-04-24
|
0.30
|
2014-05-09
|
2013-12-27
|
0.30
|
2014-01-17
|
2013-10-24
|
0.30
|
2013-11-08
|
2013-08-01
|
0.30
|
2013-08-16
|
2013-04-25
|
0.30
|
2013-05-10
|
2012-12-27
|
0.40
|
2013-01-11
|
2012-10-25
|
0.30
|
2012-11-09
|
2012-07-26
|
0.30
|
2012-08-10
|
2012-05-03
|
0.30
|
2012-05-18
|
2011-12-28
|
0.45
|
2012-01-13
|
2011-10-27
|
0.30
|
2011-11-10
|
2011-07-28
|
0.30
|
2011-08-12
|
2011-04-20
|
0.30
|
2011-05-06
|
2010-12-29
|
0.54
|
2011-01-14
|
2010-10-28
|
0.54
|
2010-11-12
|
2010-07-29
|
0.54
|
2010-08-13
|
2010-04-22
|
0.54
|
2010-05-07
|
2009-12-29
|
0.54
|
2010-01-15
|
2009-10-22
|
0.54
|
2009-11-13
|
2009-07-30
|
0.54
|
2009-08-14
|
2009-04-30
|
0.54
|
2009-05-18
|
2008-12-29
|
0.54
|
2009-01-16
|
2008-10-29
|
0.54
|
2008-11-14
|
2008-07-30
|
0.54
|
2008-08-15
|
2008-05-01
|
0.54
|
2008-05-16
|
2007-12-27
|
0.97
|
2008-01-11
|
2007-10-25
|
0.54
|
2007-11-16
|
2007-07-25
|
0.54
|
2007-08-10
|
2007-05-03
|
0.52
|
2007-05-18
|
2006-12-27
|
1.00
|
2007-01-12
|
2006-10-26
|
0.50
|
2006-11-14
|
2006-07-26
|
0.50
|
2006-08-14
|
2006-04-28
|
0.48
|
2006-05-15
|
2005-12-28
|
0.91
|
2006-01-13
|
2005-10-27
|
0.46
|
2005-11-14
|
2005-07-27
|
0.46
|
2005-08-12
|
2005-04-28
|
0.46
|
2005-05-16
|
2004-12-29
|
0.74
|
2005-01-14
|
2004-10-28
|
0.46
|
2004-11-15
|
2004-07-28
|
0.55
|
2004-08-13
|
2004-05-05
|
0.41
|
2004-05-17
|
2003-12-29
|
0.76
|
2004-01-14
|
2003-10-29
|
0.36
|
2003-11-14
|
2003-07-29
|
0.36
|
2003-08-14
|
2003-04-30
|
0.36
|
2003-05-15
|
2002-12-27
|
0.36
|
2003-01-14
|
2002-10-29
|
0.36
|
2002-11-14
|
2002-07-30
|
0.43
|
2002-08-14
|
2002-05-01
|
0.47
|
2002-05-15
|
2001-12-27
|
0.47
|
2002-01-14
|
2001-10-29
|
0.47
|
2001-11-14
|
2001-08-01
|
0.47
|
2001-08-14
|
2001-05-04
|
0.47
|
2001-05-15
|
2000-12-27
|
1.37
|
2001-01-19
|
2000-10-27
|
0.47
|
2000-11-14
|
2000-07-27
|
0.47
|
2000-08-14
|
2000-05-04
|
0.45
|
2000-05-15
|
1999-12-29
|
1.46
|
2000-01-19
|
1999-10-27
|
0.43
|
1999-11-12
|
1999-07-28
|
0.43
|
1999-08-13
|
1999-05-03
|
0.41
|
1999-05-14
|
1998-12-29
|
0.71
|
1999-01-15
|
1998-10-28
|
0.40
|
1998-11-12
|
1998-07-29
|
0.40
|
1998-08-14
|
1998-05-04
|
0.40
|
1998-05-15
|
1997-12-29
|
1.70
|
1998-01-22
|
1997-10-29
|
0.75
|
1997-11-14
|
1997-07-29
|
0.73
|
1997-08-14
|
1997-05-01
|
0.71
|
1997-05-14
|
1996-12-27
|
0.70
|
1997-01-16
|
1996-10-29
|
0.70
|
1996-11-14
|
1996-07-29
|
0.70
|
1996-08-08
|
1996-04-26
|
0.70
|
1996-05-15
|
1995-12-27
|
1.62
|
1996-01-18
|
1995-10-27
|
0.70
|
1995-11-09
|
1995-07-27
|
0.70
|
1995-08-10
|
1995-04-25
|
0.70
|
1995-05-11
|
1994-12-23
|
0.22
|
1995-01-19
|
1994-11-01
|
0.70
|
1994-11-14
|
1994-07-27
|
0.70
|
1994-08-11
|
1994-04-26
|
0.70
|
1994-05-12
|
1993-12-27
|
0.70
|
1994-01-13
|
1993-10-27
|
0.70
|
1993-11-12
|
1993-07-28
|
0.70
|
1993-08-12
|
1993-04-27
|
0.70
|
1993-05-13
|
1992-12-24
|
0.70
|
1993-01-14
|
1992-10-26
|
0.70
|
1992-11-13
|
1992-07-28
|
0.70
|
1992-08-13
|
1992-04-24
|
0.70
|
1992-05-14
|
1991-12-24
|
0.70
|
1992-01-16
|
1991-10-25
|
0.70
|
1991-11-14
|
1991-07-25
|
0.70
|
1991-08-15
|
1991-04-24
|
0.70
|
1991-05-16
|
1990-12-24
|
0.70
|
1991-01-17
|
1990-10-25
|
0.70
|
1990-11-15
|
1990-07-25
|
0.70
|
1990-08-16
|
1990-04-24
|
0.70
|
1990-05-17
|
1989-12-22
|
0.70
|
1990-01-18
|
1989-10-27
|
0.70
|
1989-11-16
|
1989-07-25
|
0.95
|
1989-08-17
|
1989-04-26
|
0.95
|
1989-05-18
|
1988-12-23
|
0.95
|
1989-01-19
|
1988-10-25
|
0.95
|
1988-11-17
|
1988-07-25
|
0.95
|
1988-08-18
|
1988-04-25
|
0.95
|
1988-05-12
|
1987-12-24
|
0.95
|
1988-01-21
|
1987-10-26
|
0.95
|
1987-11-12
|
1987-07-27
|
0.90
|
1987-08-13
|
1987-04-24
|
0.90
|
1987-05-14
|
1987-01-26
|
0.90
|
1987-02-12
|
1986-10-27
|
0.90
|
1986-11-13
|
1986-07-25
|
0.85
|
1986-08-14
|
1986-04-24
|
0.80
|
1986-05-15
|
1984-07-25
|
0.70
|
1984-08-16
|
1984-04-24
|
0.66
|
1984-05-17
|
1984-01-25
|
0.65
|
1984-02-16
|
1983-10-25
|
0.64
|
1983-11-17
|
1983-07-25
|
0.64
|
1983-08-18
|
1983-04-25
|
0.64
|
1983-05-12
|
1983-01-25
|
0.64
|
1983-02-17
|
1982-10-25
|
0.64
|
1982-11-18
|
1982-07-26
|
0.64
|
1982-08-12
|
1982-04-26
|
0.64
|
1982-05-13
|
1982-01-25
|
0.64
|
1982-02-18
|
1981-10-26
|
0.64
|
1981-11-12
|
1981-07-27
|
0.62
|
1981-08-13
|
1981-04-24
|
0.50
|
1981-05-14
|
1981-01-26
|
0.46
|
1981-02-12
|
1980-10-27
|
0.46
|
1980-11-13
|
1980-07-25
|
0.45
|
1980-08-14
|
1980-04-23
|
0.45
|
1980-05-15
|
1980-01-24
|
0.43
|
1980-02-13
|
1979-10-24
|
0.43
|
1979-11-14
|
1979-07-24
|
0.43
|
1979-08-15
|
1979-04-23
|
0.42
|
1979-05-16
|
1979-01-24
|
0.42
|
1979-02-14
|
1978-10-24
|
0.42
|
1978-11-15
|
1978-07-24
|
0.41
|
1978-08-09
|
1978-04-24
|
0.41
|
1978-05-10
|
1978-01-29
|
0.40
|
1978-02-15
|
1977-10-24
|
0.38
|
1977-11-09
|
1977-07-24
|
0.38
|
1977-08-10
|
1977-04-24
|
0.38
|
1977-05-11
|
1977-01-24
|
0.40
|
1977-02-16
|
